Physician profile
Michael J Angel
NPI 1811151947
$4,072.63
in general payments reported to CMS, 2019-2025
22 companies · $60.91 in 2025
The $60.91 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $992 · 2020: $219 · 2021: $1,417 · 2022: $510 · 2023: $588 · 2024: $287 · 2025: $60.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $935.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $1,200.00 | 2021 | |
| Stryker Corporation | $717.87 | 2019-2025 | Aequalis Perform, Gamma, Aequalis Perform Reversed |
| Hitachi Healthcare Americas Corp. | $316.24 | 2019 | |
| Joint Restoration Foundation, INC. | $289.48 | 2019 | |
| Bioventus LLC | $259.43 | 2022-2025 | Durolane, Durolane |
| Djo, LLC | $228.57 | 2022-2024 | Cmf |
| Zimmer Biomet Holdings, INC. | $214.58 | 2023 | Comprehensive, Comprehensive |
| Medartis INC. | $199.48 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $127.73 | 2022-2023 | Euflexxa |
| Linvatec Corporation | $113.63 | 2022-2023 | Biobrace 23mm |
| Arcuro Medical INC | $74.69 | 2024 | Superball |
| Orthofix Medical, INC. | $64.08 | 2019 | |
| Smith+Nephew, INC. | $48.24 | 2019 | |
| Merck Sharp & Dohme LLC | $39.65 | 2023-2024 | Bridion, Verquvo |
| Endo Pharmaceuticals INC. | $39.48 | 2021-2023 | Xiaflex |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $34.55 | 2019-2020 | |
| Depuy Synthes Sales INC. | $25.60 | 2021-2024 | Monovisc, Orthovisc |
| Endo USA, INC. | $20.61 | 2024 | Xiaflex |
| Molnlycke Health Care US, LLC | $19.15 | 2023 | Avance, Mepilex Border Post-Op Ag |
| Biomarin Pharmaceutical INC. | $16.77 | 2019 | |
| Nevro Corp. | $11.59 | 2020 | |
| Convatec INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Angel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.